EVIDENCE FOR A PLATELET-ACTIVATING-FACTOR RECEPTOR ON HUMAN ALVEOLAR MACROPHAGES

In this report we demonstrate evidence which strongly suggests that human alveolar macrophages possess receptors for the platelet activating factor (PAF). We investigated the effects of PAF by measuring (a) the intracellular free calcium concentration [Ca2+]i, using the fura-2 method in single isolated cells and (b) the production of superoxide anion. PAF increased [Ca2+]i in a dose-dependent manner (EC50=1×10-8 M), whereas lyso-PAF had no effect. The initial increase of [Ca2+]i was followed by a slow decrease to a sustained elevation of [Ca2+]i significantly above basal values. While the initial rise in [Ca2+]i was only slightly reduced in Ca2+-free medium (1mM EGTA), the sustained phase was totally abolished. The sustained calcium increase was also blocked after preincubation of AM with the calcium-channel blocker nitrendipine. PAF increased the production of superoxide anion (O2) by human alveolar macrophages in a dose- dependent manner. The effects of PAF on [Ca2+]i and (O2) could be blocked by the PAF-specific antagonist WEB 2086 dose dependently, indicating a receptor-mediated event. © 1991.